Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning
Aarhus, Denmark
University hospital in Aarhus
Palle Juul-Jensens Boulevard 69 indgang F plan 3 F302, 8200 Aarhus
About Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Actelion
2
Pfizer
2
Clinical Trials at Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning
During the past decade, Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment
2019-01-23
2022-06-07
Terminated
131
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension
2020-06-30
2026-09-21
Recruiting
900
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning
According to Clinical.Site data, the most researched conditions in "Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning" are
"Cardiovascular Disease" (2 trials), "Chronic Thromboembolic Pulmonary Hypertension" (1 trials) and "Pulmonary Arterial Hypertension" (1 trials). Many other conditions were trialed in "Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning" in a lesser frequency.
Clinical Trials Intervention Types at Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning
Most popular intervention types in "Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "bococizumab (PF-04950615)" (2 trials), "Macitentan 10 mg" (1 trials), "Macitentan 37.5 mg" (1 trials) and "Macitentan 75 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning
The vast majority of trials in "Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning" are
4 trials for "All" genders.
Clinical Trials Status at Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning
Currently, there are NaN active trials in "Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".